Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos
January 07, 2019 10:43 ET
|
MaRS Innovation
Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...
Fibrocor Therapeutics Appoints Its First President & CEO
November 28, 2017 08:00 ET
|
Fibrocor Therapeutics
Toronto, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics (Fibrocor) announced today that Mark Steedman has been appointed as its first president and CEO, and will serve as a member of...